NeurologyLive® Mind Moments®

148: Navigating Transition: Supporting Young Adults With Epilepsy Into Adult Care


Listen Later

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, "Navigating Transition: Supporting Young Adults With Epilepsy Into Adult Care," Danielle Andrade, MD, MSc, adult neurologist at the University of Toronto and co-chair of the ILAE Transition Task Force, discussed the critical process of moving pediatric patients with epilepsy into adult care. She highlighted findings from the task force’s global survey on transition practices, revealing major differences across regions. Andrade also shared important considerations for students with epilepsy entering college, including lifestyle management and the “perfect storm” of seizure triggers like sleep deprivation, alcohol, and medication adherence. She spoke on the vital role of reproductive health discussions, the utility of readiness questionnaires, and the challenges of coordinating multi-specialty care. Finally, Andrade underscored the importance of clear communication between pediatric and adult neurologists, as well as the need for stronger guidelines and education worldwide.


Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.

Episode Breakdown:
  • 1:00 – Global survey findings on epilepsy transition of care
  • 2:10 – Key considerations for students with epilepsy entering college
  • 3:50 – Ensuring continuity of care during transition into adulthood
  • 5:45 – Neurology News Minute
  • 7:30 – Common challenges and strategies to overcome them
  • 9:30 – Final thoughts on back-to-school care and global survey insights

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • Ianalumab Meets Primary End Points in Phase 3 NEPTUNUS Trials of Sjögren’s Disease
    • Praxis’ Vormatrigine Shows Significant Ability to Reduce Seizure Incidence in Phase 2 RADIANT Study
    • FDA Denies Approval for Friedreich Ataxia Agent Vatiquinone, Citing More Efficacy Needed

    • Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
      ...more
      View all episodesView all episodes
      Download on the App Store

      NeurologyLive® Mind Moments®By NeurologyLive

      • 4.6
      • 4.6
      • 4.6
      • 4.6
      • 4.6

      4.6

      10 ratings


      More shows like NeurologyLive® Mind Moments®

      View all
      NEJM This Week by NEJM Group

      NEJM This Week

      321 Listeners

      Neurology® Podcast by American Academy of Neurology

      Neurology® Podcast

      302 Listeners

      Practical Neurology Podcast by BMJ Group

      Practical Neurology Podcast

      49 Listeners

      The Clark Howard Podcast by Clark Howard

      The Clark Howard Podcast

      5,457 Listeners

      JAMA Neurology Author Interviews by JAMA Network

      JAMA Neurology Author Interviews

      12 Listeners

      BMJ Best Practice Podcast by BMJ Group

      BMJ Best Practice Podcast

      21 Listeners

      Neurology Today in 5 by American Academy of Neurology

      Neurology Today in 5

      25 Listeners

      Neurology Minute by American Academy of Neurology

      Neurology Minute

      133 Listeners

      Dateline NBC by NBC News

      Dateline NBC

      47,622 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      16,096 Listeners

      Movers and Shakers: a podcast about life with Parkinson's by Podot

      Movers and Shakers: a podcast about life with Parkinson's

      106 Listeners

      Continuum Audio by American Academy of Neurology

      Continuum Audio

      80 Listeners

      Chanticleer by Australian Financial Review

      Chanticleer

      21 Listeners

      The Top Line by Fierce Life Sciences

      The Top Line

      13 Listeners

      The Economics Show by Financial Times

      The Economics Show

      140 Listeners